ArticleMolecules (Basel, Switzerland)2025
Rapid Profiling of Volatile Organic Compounds Associated with Plant-Based Milks Versus Bovine Milk Using an Integrated PTR-ToF-MS and GC-MS Approach.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Transformation of Agro-Industrial By-Products into High-Value Animal-Derived Foods: Bioactive Compounds, Microbiome-Mediated Biotransformation, Metabolomic Traceability and Circular Valorization.Molecules (Basel, Switzerland) · 2026Review
- Unraveling the Impacts of Preprocessing on the Metabolite Profile of Bitter Almond Using UPLC-MS/MS and GC-MS Analysis.ACS omega · 2026Article
- Analytical Methods for the Characterisation of Aroma Compounds in Milk.Foods (Basel, Switzerland) · 2026Review
- Embedded MOX-Based Volatilomic Sensing for Real-Time Classification of Plant-Based Milk Beverages.Sensors (Basel, Switzerland) · 2026Article
- On the use of TabPFN on mass spectrometry analysis of volatile organic compounds.Scientific reports · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The growing demand for plant-based beverages has underscored the importance of investigating their volatile profiles, which play a crucial role in sensory perception and consumer acceptance. This is especially true for plant-based milks (PBMs) that have a clear reference model in bovine milk. This study characterises the volatile organic compounds (VOCs) in soy, almond and oat beverages compared to bovine milk using proton transfer reaction-time of flight-mass spectrometry (PTR-ToF-MS) as a rapid and noninvasive screening tool, complemented by gas chromatography-mass spectrometry (GC-MS) for compound identification. A total of 188 mass peaks were detected by PTR-ToF-MS, all showing significant differences from the blank, while GC-MS allowed the identification of 50 compounds, supporting the tentative identifications performed with PTR-MS analysis. In order to facilitate a comparison of different milks, after statistical analysis, these 188 mass peaks were further categorised into two groups: one consisting of VOCs with minimal variability across all samples and another comprising VOCs with significantly different abundances, distinctly characterising each beverage. Principal component analysis revealed a clear separation between bovine milk and PBMs, with almond beverages exhibiting the richest volatilome, while oat beverages displayed a more homogeneous volatile profile. PTR-ToF-MS demonstrated its ability to analyse volatile profiles rapidly, with excellent complementarity to GC-MS in terms of analytical versatility. The results provided a valuable basis for testing new experimental designs aimed to characterise and enhance flavour profiles in plant-based beverages, also after processing, in case of new product development that considers using these milks as raw materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.